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distribution of labeled visceral endoderm
cells to see how they become replaced
by the invading epiblast-derived endo-
derm. All three methods give the same re-
sult: epiblast-derived endoderm cells in-
sert into the endodermal layer as single
cells, which is confirmed very clearly by
time-lapse movies. Surprisingly, almost
all of the visceral endoderm cells appear
to persist and even to proliferate, although
they become gradually diluted by the
newcomers. It will be interesting in future
to determine whether, as in the chick, pro-
spective mouse endoderm cells travel
within a middle (mesendoderm) layer
before joining the endoderm as single
cells.
Another surprising observation is that
the persisting visceral endoderm cells
can be detected as late as the 16–18 so-
mite stage in the lining of the gut, indicat-
ing that these cells do contribute to the
embryo proper. Furthermore, these cells
tend to surround embryonic structures
that have known signaling properties,
such as the node and head process/no-
tochord (Figures 1B and 1C). The authors
are rightly cautious to avoid speculating
on the significance of this, but no doubt
others will soon propose that their con-
tinued presence around these structures
could explain some of the signaling func-
tions of these centers. One hopes that
any such proposals will be accompanied
by evidence as compelling as that in the
present study, which is a model of how
shrewd observations, untainted by pre-
conceptions and supported by several
very well-designed embryological exper-
iments, can reveal that even the most
widely accepted ‘‘facts’’ can sometimes
be wrong.
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New work by Lehembre et al. in The EMBO Journal reveals that the cell-adhesion molecule, NCAM, is at the
heart of crosstalk between E-cadherin loss and reciprocal focal adhesion assembly during the epithelial to
mesenchymal transition (EMT). NCAM upregulation induces the formation of novel signaling complexes
that correlate with NCAM-dependent focal adhesion assembly, migration, and cancer cell invasion.E-cadherin is a multitissue tumor-sup-
pressor protein which is often lost, or dys-
functional, in epithelial cancers (Cavallaro
and Christofori, 2004). As a consequence,
cell-cell adhesions (adherens junctions)
are weakened, and this weakening facili-
tates cells’ breaking free from their neigh-
bors. In addition, cells assemble dynamic
b1-integrin-mediated focal adhesions or
focal contacts and assume a migratory
phenotype more reminiscent of mesen-
chymal cells. Epithelial to mesenchymal494 Developmental Cell 15, October 14, 200transition (EMT) occurs during embryonic
development and is presumed to play
a role in acquisition of invasive and malig-
nant phenotype (Lee et al., 2006; Yang
and Weinberg, 2008). Moreover, TGFb
(which is used extensively in the new
study by Lehembre et al. [2008] in The
EMBO Journal) promotes EMT by Smad-
mediated transcriptional activation of
HMGA2, which induces expression of
Snail, Twist, and Slug that, in turn, repress
E-cadherin (Thuault et al., 2006). The im-8 ª2008 Elsevier Inc.portance of EMT during normal develop-
ment and pathophysiological processes
has justifiably led to its intense investiga-
tion over many years. However, we still
lack a full understanding of the critical me-
diators of EMT initiation and maintenance
and of the mechanisms involved in recip-
rocal regulation of E-cadherin and the
components of integrin-mediated focal
adhesions.
In a new study, several experimental
cell systems, transgenic mouse models,
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Induction of EMT, induced via TGFb or cadherin loss, not only causes NCAM-mediatedweakening of cell-cell adhesions, but also formation and dynamic turnover
of focal adhesions. This is accompanied by elevated NCAM expression, which leads to altered signaling complexes. Specifically, NCAM binding to PLCg and
cortactin is diminished, and NCAM forms a complex with Fyn (and likely FAK downstream). The induced complexes sediment in detergent insoluble membrane
fractions of sucrose gradients, implying that these are in lipid rafts. These signaling changes are linked to induction of the more mesenchymal and migratory
phenotype associated with aggressive cancers of epithelial origin. Knockdown of NCAM induces the reversal of EMT (i.e., MET [mesenchymal to epithelial
transition]).Developmental Cell 15, October 14, 2008 ª2008 Elsevier Inc. 495and tumor material, are used to address
thoroughly the role of the Ig domain
homotypic adhesion protein, NCAM, in
promoting EMT (Lehembre et al., 2008).
Intervention strategies clearly establish
that expression of NCAM is commonly
upregulated and promotes an adhesion
switch during EMT that is associated
with cancer invasion. In particular, TGFb
treatment or diminished E-cadherin func-
tion induces changes in adhesion protein
expression that is typical of either ‘‘cad-
herin switching’’ (i.e., reduced E-cadherin
and elevated N-cadherin) or full EMT, dur-
ing which vimentin becomes expressed.
In both cases, NCAM is induced to a
greater or lesser extent. Although TGFb
acts via Smads to exert this effect, the
precise mechanism by which NCAM pro-
moter activity is regulated by E-cadherin
loss or by TGFb-induced Smad activity
remains to be established.
NCAM is not only needed for induction
of EMT but also for maintenance of the
mesenchymal state. In keeping with
a more general role, enforced expression
of NCAM promotes mesenchymal-like
properties in some epithelial cells in cul-
ture. For example, there is reciprocal
staining of E-cadherin andNCAM in tumor
sections from the RipTag2 mouse model
of pancreatic cancer, and NCAM defi-ciency leads to aberrant persistence of
E-cadherin expression. The reciprocal
regulation of E-cadherin and NCAM in tu-
mors in vivo may explain why reduced
NCAM expression promotes tumor dis-
semination (Perl et al., 1999). In fact, anal-
ogous results are seen using a mouse
model of lobular breast carcinogenesis
(Derksen et al., 2006) and human patient
samples, where the reciprocal expression
of NCAM and E-cadherin correlate
strongly with invasive and well-differenti-
ated phenotypes, respectively. These
findings imply that the causal role of
NCAM during EMT is indeed relevant to
human cancer.
However, the role of NCAM is not
limited to its relationship to E-cadherin.
Perhaps the most striking findings of the
new study are that NCAM has a very clear
role in assembly of b1-integrin-dependent
focal adhesions in cells that retain epithe-
lial-mesenchymal plasticity, and that
this is accompanied by changes in
NCAM-associated signaling complexes
and redistribution to distinct membrane
microdomains. NCAM induces FAK phos-
phorylation and enhanced b1-integrin-
dependent cell spreading, while NCAM-
expressing MDCK cells scatter at low
density and become extruded frommixed
monolayers, migrating on top of their epi-thelial neighbors that do not overexpress
NCAM at high density. However, NCAM
knockdown causes NMuMG cells to mi-
grate faster in both scratch wound and
Boyden chamber assays, suggesting
that both assembly and dynamic turnover
of cell-matrix adhesions are influenced by
NCAM.
A switch between two distinct, appar-
ently mutually exclusive, signaling com-
plexes may provide the mechanism by
which NCAM regulates focal adhesion as-
sembly and turnover. Under normal con-
ditions, NCAM associates with FGFR,
PLCg, and cortactin and sediments in de-
tergent-soluble membrane fractions in
sucrose gradients. Upon TGFb treatment,
NCAM no longer associates with PLCg or
cortactin, instead associating with Fyn,
whose tyrosine phosphorylation is en-
hanced. Moreover, a proportion of
NCAM, Fyn, and FAK now cosediment in
detergent-insoluble membrane fractions,
suggesting that NCAM switches binding
partners and associates with the adhe-
sion-linked tyrosine kinases Fyn, and
perhaps also FAK, in lipid rafts (Figure 1).
These findings raise a number of interest-
ing questions. For example, does NCAM
associate solely with Fyn, or are other
Src family kinases (Src and/or Yes) in-
volved, and is FAK also present in the
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Previewssame complex at lipid rafts? Molecular in-
tervention is needed to establish whether
formation of the proposed NCAM/Fyn/
FAK complex at lipid rafts mediates focal
adhesion assembly, and turnover, during
EMT. The authors noted that the NCAM-
FGFR complex persists after TGFb
treatment, and it would be interesting to
determine whether or not a proportion of
FGFR is also present in lipid rafts. It had
been shown previously that NCAM
forms a complex with Fyn and FAK in lipid
rafts upon homodimerization in neurons
(Beggs et al., 1997); the new study
suggests this complex may also a role in
mediating NCAM-dependent events dur-
ing EMT. Whether FAK, or other integrin
effectors, not only influences focal adhe-
sion assembly but also feeds back on
E-cadherin dynamics or stability at the
membrane is an intriguing possibility.
The localized expression of NCAM
almost exclusively at invasive tumors
marginsmay have precluded the inclusion
of NCAM in ‘‘signatures’’ associated with
poor prognosis, as derived from large-
scale microarray analyses. However, tis-496 Developmental Cell 15, October 14, 200sue microarray analysis may reveal the
potential prognostic significance of
NCAM expression. The current study
highlights the undoubted importance of
NCAM in promoting signaling changes at
specific membrane microdomains, and
in inducing both focal adhesion formation
and E-cadherin loss during EMT. Conse-
quently, NCAM has a central role in
promoting one set of dynamic adhesion
complexes (focal adhesions), apparently
at the expense of another (adherens junc-
tions), and so inducing migratory proper-
ties associated with aggressive cancer
phenotypes. NCAM, and perhaps other
related Ig domain-containing adhesion
proteins, may prove to be useful as early
markers of EMT in vivo. Early changes as-
sociated with EMT are difficult to visualize
morphologically in tumor sections, yet
early detection of EMT may predict likely
invasive behavior and could aid decisions
about appropriate treatment. Also, there
is substantial interest now in anti-EMT
therapeutic strategies, which will require
good biomarkers of early changes during
EMT to monitor efficacy.8 ª2008 Elsevier Inc.REFERENCES
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